MYOSTEATOSIS: A NEW MARKER OF MUSCLE QUALITY IN CHRONIC KIDNEY DISEASE STRONGLY ASSOCIATED WITH MORTALITY

被引：0
|
作者：
Donato, Beatriz [1 ]
Almeida, Ana Rita [1 ]
Raimundo, Mario Castro [1 ]
Velho, Sonia [2 ]
Primitivo, Ana [3 ]
Correia, Filipa [4 ]
Falcao, Luis [1 ]
Teixeira, Catarina [1 ]
Silva, Sonia [1 ]
De Almeida, Edgar A. F. [1 ]
机构：
[1] Hosp Beatriz Angelo, Nephrol, Loures, Portugal
[2] Hosp Beatriz Angelo, Nutr & Dietet, Loures, Portugal
[3] Hosp Beatriz Angelo, Radiol, Loures, Portugal
[4] Univ Lisbon, Fac Med, Nutr & Dietet, Loures, Portugal
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5181
引用
收藏
页码：I607 / I607
页数：1
相关论文
共 50 条
  • [21] Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis
    Ebadi, Maryam
    Tsien, Cynthia
    Bhanji, Rahima A.
    Dunichand-Hoedl, Abha R.
    Rider, Elora
    Motamedrad, Maryam
    Mazurak, Vera C.
    Baracos, Vickie
    Montano-Loza, Aldo J.
    CELLS, 2022, 11 (08)
  • [22] THROMBOMODULIN AS A NEW MARKER OF ENDOTHELIAL DYSFUNCTION IN CHRONIC KIDNEY DISEASE IN CHILDREN
    Drozdz, Dorota
    Latka, Monika
    Drozdz, Tomasz
    Sztefko, Krystyna
    Kwinta, Przemko
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1875 - 1875
  • [23] Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
    Drozdz, Dorota
    Latka, Monika
    Drozdz, Tomasz
    Sztefko, Krystyna
    Kwinta, Przemko
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [24] CHRONIC KIDNEY DISEASE High eGFR and mortality: high true GFR or a marker of frailty?
    Shastri, Shani
    Sarnak, Mark J.
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (12) : 680 - 682
  • [25] Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease
    Tachi, Yoshihiko
    Kozuka, Akihiro
    Hirai, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Kuzuya, Teiji
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Goto, Hidemi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (09) : 1659 - 1666
  • [26] Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
    Gustavo Lenci Marques
    Shirley Hayashi
    Anna Bjällmark
    Matilda Larsson
    Miguel Riella
    Marcia Olandoski
    Bengt Lindholm
    Marcelo Mazza Nascimento
    Scientific Reports, 11
  • [27] Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease
    Castillo-Rodriguez, Esmeralda
    Fernandez-Prado, Raul
    Martin-Cleary, Catalina
    Soledad Pizarro-Sanchez, Maria
    Dolores Sanchez-Nino, Maria
    Belen Sanz, Ana
    Fernandez-Fernandez, Beatriz
    Ortiz, Alberto
    NEPHRON, 2017, 136 (04) : 263 - 267
  • [28] Painless Myocardial Ischemia Is Associated with Mortality in Patients with Chronic Kidney Disease
    Wetmore, James B.
    Broce, Mike
    Malas, Amer
    Almehmi, Ammar
    NEPHRON CLINICAL PRACTICE, 2012, 122 (1-2): : 9 - 16
  • [29] Obesity-associated mortality risk: Chronic kidney disease in focus
    Spatola, L.
    Dozio, E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (02) : 212 - 213
  • [30] New Statin Use is Associated with a lower risk of mortality among older Veterans with Chronic Kidney Disease
    不详
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 : S256 - S257
12345